Investing

Agios Pharmaceuticals : AGIO

AGIO

Stock Data

$37.58

$0.50 (1.35%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Agios Pharmaceuticals Inc is a pioneering biopharmaceutical company based in Cambridge, Massachusetts, focusing on creating innovative medicines that target cellular metabolism. Its flagship product, PYRUKYND, is a groundbreaking treatment for hemolytic anemias, activating specific enzymes to combat the disease. Agios is also developing treatments for myelodysplastic syndrome and phenylketonuria, alongside research into combating polycythemia vera, a rare blood disorder, through preclinical studies. Founded in 2007, Agios is at the forefront of addressing complex diseases with cutting-edge science.

All Agios Pharmaceuticals Articles

6 Articles

Chris Lange | Nov 17, 2022 at 10:49 AM EST

Retail Earnings Fail to Rescue Broad Markets: Analysts Upgrade or Downgrade Nio, Salesforce, Target and More

Thursday’s additional top analyst upgrades and downgrades were on Advance Auto Parts, AppLovin, Nio, Norfolk Southern, Norwegian Cruise Line, Quest…

Chris Lange | Jul 30, 2021 at 11:48 AM EDT

Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades

24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including…

Chris Lange | Jul 1, 2021 at 9:12 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: AutoNation, Enbridge, Gap, JinkoSolar, Micron, Nvidia, Tractor Supply, Twilio and More

Thursday’s top analyst upgrades and downgrades included AutoNation, Enbridge, Gap, JinkoSolar, Micron Technology, Nvidia, Tractor Supply, Twilio and Vertex Pharmaceuticals.

Chris Lange | Jun 10, 2021 at 12:12 PM EDT

American Airlines, Biogen, Dow and More Thursday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including American Airlines,…

Chris Lange | Mar 1, 2021 at 12:01 PM EST

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon’s Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas,…

Chris Lange | Dec 21, 2020 at 9:54 AM EST

Agios Pharma’s Big Bet on Anemia

Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.